-
公开(公告)号：USRE35224E
公开(公告)日：1996-04-30
申请号：US23891
申请日：1993-02-26
IPC分类号： C07D233/54 , A61K31/415 , C07D233/64
CPC分类号： C07D233/64 , Y10S530/807
摘要： Histamine derivatives are disclosed which find use as effect and tissue-specific immune modulators. Specifically, the primary terminal nitrogen in histamine is derivatized to introduce a variable length side chain having 0 to 1 branch of from 1 to 3 carbons; 0 to 2 non-oxo-carbonyl groups; 0 to 4 heteroatoms, other than the non-oxo carbonyl oxygen; 0 to 1 aryl or alkylaryl group; and 0 to 1 functionally bound amino acid, polypeptide, or protein or derivative thereof.
摘要翻译： 公开了组胺衍生物，其用作效应和组织特异性免疫调节剂。 具体地，将组胺中的第一末端氮衍生化，以引入具有1至3个碳的0至1个支链的可变长度侧链; 0至2个非羰基羰基; 0至4个除非羰基氧之外的杂原子; 0至1个芳基或烷基芳基; 和0至1个功能结合的氨基酸，多肽或其蛋白质或其衍生物。
-
2.发明授权Process of making GaAs electrical circuit devices with Langmuir-Blodgett insulator layer 失效用Langmuir-Blodgett绝缘子层制造GaAs电路器件的工艺
公开(公告)号：US5079179A
公开(公告)日：1992-01-07
申请号：US618578
申请日：1990-11-27
申请人： Jack Josefowicz , David Rensch , Vladimir Rodov , Meir Bartur , Debra Marr-Leisy
发明人： Jack Josefowicz , David Rensch , Vladimir Rodov , Meir Bartur , Debra Marr-Leisy
IPC分类号： H01L21/28 , H01L21/312 , H01L29/51 , H01L29/94
CPC分类号： H01L29/513 , H01L21/28158 , H01L21/28264 , H01L21/3128 , H01L29/51 , H01L29/94 , Y10S438/91 , Y10S438/939
摘要： A GaAs circuit structure is described which interposes a Langmuir-Blodgett (L-B) layer between the substrate and a conductive contact. The thickness of the layer is controlled to determine the operating characteristics of the device. The head group of the L-B molecule is chosen so that it passivates the surface states of the particular GaAs substrate being used. Certain preferred acids and amino head groups are disclosed. The L-B layer has been found to both increase the gate barrier height for an FET, and to passivate dangling bonds and surfaces defects in the GaAs substrate to enable inversion mode operation. Specific FET and diode devices are described.
摘要翻译： 描述了在衬底和导电接触之间插入Langmuir-Blodgett（L-B）层的GaAs电路结构。 控制层的厚度以确定装置的操作特性。 选择L-B分子的头基，使其钝化正在使用的特定GaAs衬底的表面状态。 公开了某些优选的酸和氨基头基。 已经发现L-B层既增加了FET的栅极势垒高度，又钝化了GaAs衬底中的悬挂键和表面缺陷，以实现反模式操作。 具体描述了FET和二极管器件。
-
公开(公告)号：US5516509A
公开(公告)日：1996-05-14
申请号：US326180
申请日：1994-10-17
CPC分类号： A61K8/731 , A61K8/35 , A61K8/8152 , A61Q3/02 , A61K2800/81
摘要： A clear, photocurable coating composition to be applied over wet nail polish on a nail for binding with the wet nail polish upon exposure to ultraviolet light, consisting of: between 5% and 50% by weight of a film-forming polymer selected from the group consisting of:i) cellulose estersii) acrylic polymers,between 2% and 15% by weight of a photoinitiator selected from the group consisting of:i) benzophenoneii) alkylphenyl ketone, andiii) cyclohexylphenyl ketone;and between 40% and 85% by weight of a photoreactive monomer selected from the group consisting of methacrylic acid esters.
摘要翻译： 一种透明的，可光固化的涂料组合物，其用于指甲上的湿指甲油上，用于在暴露于紫外线下与湿指甲油结合，该组合物包含：5重量％至50重量％的选自下组的成膜聚合物 由以下组成：i）纤维素酯ii）丙烯酸聚合物，2重量％至15重量％的选自以下的光引发剂：i）二苯甲酮ii）烷基苯基酮，和iii）环己基苯基酮; 和40重量％至85重量％的选自甲基丙烯酸酯的光反应性单体。
-
公开(公告)号：US5407666A
公开(公告)日：1995-04-18
申请号：US42555
申请日：1993-04-05
CPC分类号： A61K8/90 , A61K8/8152 , A61Q3/02 , A61K2800/81
摘要： A photocurable coating composition to be applied directly onto a nail surface and is rapidly curable upon exposure to ultraviolet light, comprising between 5% and 65% by weight of a film-forming polymer selected from the group consisting essentially of:i) cellulose derivativesii) acrylic polymers;between 2% and 20% by weight of a photoinitiator selected from the group consisting essentially of:i) acetophenoneii) benzophenoneiii) alkylphenyl ketoneiv) cyclohexylphenyl ketone;and between 10% and 90% by weight of a photoreactive monomer selected from the group consisting essentially of:i) methacrylic acid estersii) diesters of methacrylic acid,where the percentages by weight are based on the composition total weight.
摘要翻译： 一种可光固化的涂料组合物，其直接施加到指甲表面上，并且在暴露于紫外光下可快速固化，包含5％至65％重量的成膜聚合物，其选自基本上由以下组成的组：i）纤维素衍生物ii ）丙烯酸聚合物; 2％至20％重量的光引发剂，其选自基本上由以下组成的组：i）苯乙酮ii）二苯甲酮iii）烷基苯基酮iv）环己基苯基酮; 和10重量％至90重量％的选自以下的光反应性单体：基本上由以下组成的组：i）甲基丙烯酸酯ii）甲基丙烯酸二酯，其中重量百分比基于组合物总重量。
-
公开(公告)号：US4996221A
公开(公告)日：1991-02-26
申请号：US2781
申请日：1987-01-13
IPC分类号： C07D233/54
CPC分类号： C07D233/64 , Y10S530/807
摘要： Histamine derivatives are disclosed which find use as effect and tissue-specific immune modulators. Specifically, the primary terminal nitrogen in histamine is derivatized to introduce a variable length side chain having 0 to 1 branch of from 1 to 3 carbons; 0 to 2 non-oxo-carbonyl groups; 0 to 4 heteroatoms, other than the non-oxo carbonyl oxygen; 0 to 1 aryl or alkyl-aryl group; and 0 to 1 functionally bound amino acid, polypeptide, or protein or derivative thereof.
摘要翻译： 公开了组胺衍生物，其用作效应和组织特异性免疫调节剂。 具体地，将组胺中的第一末端氮衍生化，以引入具有1至3个碳的0至1个支链的可变长度侧链; 0至2个非羰基羰基; 0至4个除非羰基氧之外的杂原子; 0至1个芳基或烷基 - 芳基; 和0至1个功能结合的氨基酸，多肽或其蛋白质或其衍生物。
-
公开(公告)号：US4837305A
公开(公告)日：1989-06-06
申请号：US85517
申请日：1987-08-13
申请人： Murray Goodman , Debra Marr-Leisy , Roberto P. Rosenkranz , Kenneth L. Melmon , Michael S. Verlander
发明人： Murray Goodman , Debra Marr-Leisy , Roberto P. Rosenkranz , Kenneth L. Melmon , Michael S. Verlander
IPC分类号： C07C235/74 , C07D209/08 , C07D209/48 , C07D303/22 , C07D303/24 , C07D405/12 , C07K5/065
CPC分类号： C07D209/08 , C07C235/74 , C07D209/48 , C07D303/22 , C07D303/24 , C07D405/12 , C07K5/06078
摘要： Molecular structures of .beta.-adrenergic antagonists are modified to produce biologically active compounds. The .beta.-antagonists are modified to form molecules of the general structure: ##STR1## wherein R is most generally R"--OCH.sub.2 --, and in some instances is R"--, and R"=an aryl or substituted aryl moiety; R'=--H, --CH.sub.3, or a short chain alkyl moiety; and Y=--OH, or more usually, --OAX or --NHAX, where A=an alkyl, aryl, or aralkyl moiety, and X=a terminal grouping, such as --CH.sub.3, --CF.sub.3 or --(CH.sub.2).sub.n COOH; or AX may be a carrier moiety consisting of a defined peptide or protein.
摘要翻译： β-肾上腺素能拮抗剂的分子结构被修饰以产生生物活性化合物。 β - 拮抗剂被修饰以形成通用结构的分子：其中R最通常为R“ - OCH 2 - ，并且在一些情况下为R” - ，并且R“=芳基或取代的芳基部分 ; R'= -H，-CH 3或短链烷基部分; 并且Y = -OH或更通常-OAX或-NHAX，其中A =烷基，芳基或芳烷基部分，X =末端基团，例如-CH 3，-CF 3或 - （CH 2）n COOH; 或AX可以是由限定的肽或蛋白质组成的载体部分。
-
公开(公告)号：US4687873A
公开(公告)日：1987-08-18
申请号：US733391
申请日：1985-05-10
申请人： Murray Goodman , Debra Marr-Leisy , Roberto P. Rosenkranz , Kenneth L. Melmon , Michael S. Verlander
发明人： Murray Goodman , Debra Marr-Leisy , Roberto P. Rosenkranz , Kenneth L. Melmon , Michael S. Verlander
IPC分类号： C07C235/74 , C07D209/08 , C07D209/48 , C07D303/22 , C07D303/24 , C07D405/12 , C07C125/06 , C07C103/00
CPC分类号： C07D209/08 , C07C235/74 , C07D209/48 , C07D303/22 , C07D303/24 , C07D405/12
摘要： Molecular structures of .beta.-adrenergic antagonists are modified to produce biologically active compounds. The .beta.-antagonists are modified to form molecules of the general structure: ##STR1## wherein R is most generally R"--OCH.sub.2 --, and in some instances is R"--, and R"=an aryl or substituted aryl moiety; R'=--H, --CH.sub.3, or a short chain alkyl moiety; and Y=--OH, or more usually, --OAX or --NHAX, where A=an alkyl, aryl, or aralkyl moiety, and X=a terminal grouping, such as --CH.sub.3, --CF.sub.3 or --(CH.sub.2).sub.n COOH; or AX may be a carrier moiety consisting of a defined peptide or protein.
摘要翻译： β-肾上腺素能拮抗剂的分子结构被修饰以产生生物活性化合物。 β - 拮抗剂被修饰以形成通用结构的分子：其中R最通常为R“ - OCH 2 - ，并且在一些情况下为R” - ，并且R“=芳基或取代的芳基部分 ; R'= -H，-CH 3或短链烷基部分; 并且Y = -OH或更通常-OAX或-NHAX，其中A =烷基，芳基或芳烷基部分，X =末端基团，例如-CH 3，-CF 3或 - （CH 2）n COOH; 或AX可以是由限定的肽或蛋白质组成的载体部分。
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.016 秒)
